Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting
Bio-Medicine.org,
PARIS , June 30, 2015 /- Pharnext SAS today announced that data related to its lead pleodrug PXT-3003, being developed for the…